Solitary fibrous tumors (SFTs) are a subset of fibroblastic mesenchymal soft tissue tumors with the hallmark of an NAB2–STAT6 gene fusion [1,2,3] and present a metastatic rate of up to 34% after surgical resection [4,5]. This evidence concerns the gene NAB2 and solitary fibrous tumor.